Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | cpg binding protein | 0.0031 | 0.4619 | 0.4355 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0063 | 0.9918 | 0.9918 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.2036 | 0.1318 |
Leishmania major | hypothetical protein, conserved | 0.0016 | 0.2036 | 0.5 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0007 | 0.042 | 0.5 |
Echinococcus granulosus | jumonji domain containing 1A | 0.0016 | 0.2036 | 0.1603 |
Brugia malayi | jmjC domain containing protein | 0.0063 | 0.9918 | 1 |
Trypanosoma brucei | JmjC domain, hydroxylase, putative | 0.0016 | 0.2036 | 0.5 |
Schistosoma mansoni | ubiquitously transcribed sex (X/Y) chromosome tetratricopeptide repeat protein-related | 0.0016 | 0.2036 | 0.2036 |
Loa Loa (eye worm) | CXXC zinc finger family protein | 0.003 | 0.4331 | 0.3846 |
Brugia malayi | jmjC domain containing protein | 0.0016 | 0.2036 | 0.1337 |
Schistosoma mansoni | phd/f-box containing protein | 0.0016 | 0.2036 | 0.2036 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0007 | 0.042 | 0.5 |
Trypanosoma cruzi | JmjC domain, hydroxylase, putative | 0.0016 | 0.2036 | 0.5 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0007 | 0.042 | 0.5 |
Plasmodium falciparum | JmjC domain-containing protein, putative | 0.0016 | 0.2036 | 0.5 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0063 | 0.9918 | 1 |
Trypanosoma cruzi | JmjC domain, hydroxylase, putative | 0.0016 | 0.2036 | 0.5 |
Schistosoma mansoni | cpg binding protein | 0.003 | 0.4331 | 0.4331 |
Echinococcus multilocularis | lysine specific demethylase 5A | 0.0061 | 0.963 | 1 |
Echinococcus multilocularis | JmjC domain containing protein 4 | 0.0016 | 0.2036 | 0.1654 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0007 | 0.042 | 0.5 |
Trichomonas vaginalis | chromodomain-helicase-DNA-binding protein, putative | 0.0007 | 0.042 | 0.5 |
Echinococcus granulosus | JmjC domain containing protein 4 | 0.0016 | 0.2036 | 0.1603 |
Brugia malayi | jmjC domain containing protein | 0.0061 | 0.963 | 0.9683 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0016 | 0.2036 | 0.1318 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0007 | 0.042 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0007 | 0.042 | 0.5 |
Brugia malayi | CXXC zinc finger family protein | 0.003 | 0.4331 | 0.386 |
Toxoplasma gondii | histone lysine methyltransferase SET1 | 0.0056 | 0.8854 | 1 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0016 | 0.2036 | 0.1318 |
Echinococcus granulosus | lysine specific demethylase 5A | 0.0063 | 0.9918 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.2036 | 0.1318 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0007 | 0.042 | 0.5 |
Schistosoma mansoni | phosphatidylserine receptor | 0.0016 | 0.2036 | 0.2036 |
Brugia malayi | jmjC domain containing protein | 0.0016 | 0.2036 | 0.1337 |
Echinococcus multilocularis | Transcription factor, JmjC domain containing protein | 0.0061 | 0.963 | 1 |
Schistosoma mansoni | protein phosphatase 2C | 0.0016 | 0.2036 | 0.2036 |
Onchocerca volvulus | 0.003 | 0.4331 | 0.5 | |
Schistosoma mansoni | jumonji domain containing protein | 0.0016 | 0.2036 | 0.2036 |
Plasmodium vivax | JmjC domain containing protein | 0.0016 | 0.2036 | 0.5 |
Echinococcus granulosus | Jumonji AT rich interactive domain 1B | 0.0018 | 0.2324 | 0.1911 |
Trichomonas vaginalis | chromodomain-helicase-DNA-binding protein, putative | 0.0007 | 0.042 | 0.5 |
Brugia malayi | jmjC domain containing protein | 0.0016 | 0.2036 | 0.1337 |
Echinococcus multilocularis | lysine specific demethylase 6a | 0.0016 | 0.2036 | 0.1654 |
Echinococcus multilocularis | Jumonji, AT rich interactive domain 1B | 0.0018 | 0.2324 | 0.1971 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0007 | 0.042 | 0.5 |
Brugia malayi | jmjC domain containing protein | 0.0016 | 0.2036 | 0.1337 |
Echinococcus granulosus | Transcription factor JmjC domain containing protein | 0.0061 | 0.963 | 0.9693 |
Schistosoma mansoni | cpg binding protein | 0.0031 | 0.4619 | 0.4619 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0007 | 0.042 | 0.5 |
Schistosoma mansoni | jumonji domain containing protein | 0.0061 | 0.963 | 0.963 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0007 | 0.042 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0007 | 0.042 | 0.5 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0063 | 0.9918 | 0.9918 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.2036 | 0.1318 |
Echinococcus granulosus | phd:f box containing protein | 0.0016 | 0.2036 | 0.1603 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0007 | 0.042 | 0.5 |
Schistosoma mansoni | cpg binding protein | 0.0031 | 0.4619 | 0.4619 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0007 | 0.042 | 0.5 |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.0009 | 0.0839 | 0.0339 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0007 | 0.0531 | 0.0531 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0007 | 0.042 | 0.5 |
Echinococcus multilocularis | cpg binding protein | 0.0031 | 0.4619 | 0.4493 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0016 | 0.2036 | 0.1318 |
Echinococcus granulosus | lysine specific demethylase 6a | 0.0016 | 0.2036 | 0.1603 |
Trichomonas vaginalis | helicase, putative | 0.0007 | 0.042 | 0.5 |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.0009 | 0.0839 | 0.0328 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0007 | 0.042 | 0.5 |
Echinococcus multilocularis | phd:f box containing protein | 0.0016 | 0.2036 | 0.1654 |
Echinococcus multilocularis | jumonji domain containing 1A | 0.0016 | 0.2036 | 0.1654 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.